CV Sciences, Inc. (OTCMKTS:CVSI – Get Free Report) saw a large increase in short interest in the month of September. As of September 30th, there was short interest totaling 14,190 shares, an increase of 123.1% from the September 15th total of 6,360 shares. Based on an average daily trading volume, of 1,839,462 shares, the days-to-cover ratio is currently 0.0 days. Approximately 0.0% of the shares of the company are short sold.
CV Sciences Stock Performance
CVSI traded down $0.00 during trading on Thursday, reaching $0.01. 7,444 shares of the company’s stock were exchanged, compared to its average volume of 816,222. CV Sciences has a 1 year low of $0.01 and a 1 year high of $0.10. The company’s fifty day simple moving average is $0.02 and its 200-day simple moving average is $0.02.
CV Sciences Company Profile
CV Sciences, Inc is a life sciences company focused on hemp-derived cannabidiol (CBD) consumer products. The company develops, manufactures, and markets products under its PlusCBD brand, including CBD oils, softgels, gummies, capsules, topicals, and products formulated for pets.
PlusCBD products are positioned for use in areas such as general wellness, relaxation, sleep, and recovery. CV Sciences distributes its products through e-commerce channels and a network of retail outlets, primarily in the United States, subject to applicable regulations governing hemp-derived products and dietary supplements.
Founded in 2012, CV Sciences has historically focused on cannabinoid-based consumer health products and related research.
See Also
- Five stocks we like better than CV Sciences
- Domino’s Pizza: As Cheap As It Gets, Nowhere to Go But Up
- Apple Cut iPhone 18 Orders; What Does It Mean For Suppliers?
- Failed Breakout in Tech? 3 Sectors Leading the Market Rotation
- Solaris Rides the AI Boom as Risks Mount
Receive News & Ratings for CV Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CV Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
